They coined the term “Vaccine-induced COVID-19 mimicry syndrome,” wherein aberrant splicing in Oxford/AstraZeneca’s codon-optimized SP sequence can lead to a truncated SP, lacking a transmembrane domain, which can unintentionally interact with endothelium via ACE2, mimicking COVID-19 symptoms (50). Here, ACE2 is linked to COVID-19.